Choosing the Best Amorphous Dispersion Path Before It Costs You

Choosing the right amorphous solid dispersion (ASD) strategy early can help sponsors avoid costly rework, wasted API, vendor delays, and late-stage development setbacks. In this whitepaper, AustinPx explains how sponsors can make stronger formulation decisions by screening spray drying, hot melt extrusion, and KinetiSol™ Technology in parallel. As the only CDMO able to screen all three leading ASD technologies under one roof, AustinPx offers a faster, more coordinated path for challenging oral small molecules. Readers will learn how one expert team can improve data comparison, preserve molecule-specific knowledge, and evaluate performance, stability, manufacturability, and scale-up needs earlier.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.

  • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.